Skip to main navigation Skip to search Skip to main content

Exploring ACSL4/LPCAT3/ALOX15 and SLC7A11/GPX4/NFE2L2 as potential targets in ferroptosis-based cancer therapy

  • Gaurav Gupta
  • , Asif Ahmad Bhat
  • , Ahsas Goyal
  • , Neelam Singla
  • , Saurabh Gupta
  • , Sanjay Sharma
  • , Shvetank Bhatt
  • , Kamal Dua
  • Suresh Gyan Vihar University
  • Saveetha Institute of Medical and Technical Sciences (Deemed to be University)
  • GLA University
  • Chameli Devi Institute of Pharmacy
  • Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management
  • MIT World Peace University
  • University of Technology Sydney

Research output: Contribution to journalEditorial

63 Scopus citations
Original languageEnglish
Pages (from-to)1209-1212
Number of pages4
JournalFuture Medicinal Chemistry
Volume15
Issue number14
DOIs
StatePublished - 1 Jul 2023
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • antioxidants
  • cancer
  • drug therapy
  • ferroptosis
  • reactive oxygen species

Cite this